نتایج جستجو برای: recombinant antibody

تعداد نتایج: 265306  

Journal: :Processes 2021

In the past 30 years, highly specific drugs, known as antibodies, have conquered biopharmaceutical market. addition to monoclonal antibodies (mAbs), antibody fragments are successfully applied. However, recombinant production faces challenges. Process analytical tools for monitoring and controlling processes scarce time-intensive. downstream process (DSP), affinity ligands established primary m...

2017
Todd Bradley Justin Pollara Sampa Santra Nathan Vandergrift Srivamshi Pittala Chris Bailey-Kellogg Xiaoying Shen Robert Parks Derrick Goodman Amanda Eaton Harikrishnan Balachandran Linh V. Mach Kevin O. Saunders Joshua A. Weiner Richard Scearce Laura L. Sutherland Sanjay Phogat Jim Tartaglia Steven G. Reed Shiu-Lok Hu James F. Theis Abraham Pinter David C. Montefiori Thomas B. Kepler Kristina K. Peachman Mangala Rao Nelson L. Michael Todd J. Suscovich Galit Alter Margaret E. Ackerman M. Anthony Moody Hua-Xin Liao Georgia Tomaras Guido Ferrari Bette T. Korber Barton F. Haynes

The RV144 Thai trial HIV-1 vaccine of recombinant poxvirus (ALVAC) and recombinant HIV-1 gp120 subtype B/subtype E (B/E) proteins demonstrated 31% vaccine efficacy. Here we design an ALVAC/Pentavalent B/E/E/E/E vaccine to increase the diversity of gp120 motifs in the immunogen to elicit a broader antibody response and enhance protection. We find that immunization of rhesus macaques with the pen...

2010
Puja Gupta Shuang-Yin Han Marina Holgado-Madruga Siddhartha S Mitra Gordon Li Ryan T Nitta Albert J Wong

BACKGROUND EGF receptor variant III (EGFRvIII) is the most common variant of the EGF receptor observed in human tumors. It results from the in frame deletion of exons 2-7 and the generation of a novel glycine residue at the junction of exons 1 and 8. This novel juxtaposition of amino acids within the extra-cellular domain of the EGF receptor creates a tumor specific and immunogenic epitope. EGF...

2006
Jose Baselga Larry Norton Joan Albanell Young-Mee Kim John Mendelsohn

Recombinant humanized anti-HER2 antibody, rhuMAb HER2, inhibits the growth of breast cancer cells overexpressing HER2 and has clinical activity. We explored in preclinical models its capacity to enhance the tumoricidal effects of paclitaxel and doxorubicin. In cultures of naturally HER2-overexpressing cancer cells, rhuMAb HER2 inhibited growth and enhanced the cytotoxic effects of paclitaxel. T...

2012
Hiroyuki Tanaka Madan K. Paudel Ayako Takei Junichi Sakoda Thaweesak Juengwatanatrakul Kaori Sasaki-Tabata Waraporn Putalun Wanchai De-Eknamkul Yukihiro Shoyama Satoshi Morimoto

We prepared a monoclonal antibody (mAb 1C1) showing specificity for artemisinin (AM) and artesunate (AS), and we developed an indirect competitive enzymelinked immunosorbent assay (icELISA) using this novel mAb. Moreover, we prepared a recombinant antibody derived from mAb 1C1 in order to overcome insufficient mAb production by hybridoma culture. A recombinant antigen-binding fragment (Fab) was...

Journal: :The Journal of veterinary medical science 1999
T Kashima A Hasegawa H Iwata T Inoue

Bovine L-selectin was expressed in bacteria using pGEX vector and in insect cells infected with recombinant baculovirus in order to obtain recombinant protein for preparation of specific antiserum and its functional studies. In bacterial expression, L-selectin fusion protein with glutathione S-transferase was detected in the insoluble fraction with the expected molecular weight of 60 kDa by SDS...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید